Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease
- 1 May 1998
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 43 (5) , 555-560
- https://doi.org/10.1002/ana.410430503
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Phorbol Esters Increase Dopamine Transporter Phosphorylation and Decrease Transport VmaxJournal of Neurochemistry, 1997
- Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersNuclear Medicine and Biology, 1996
- Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brainSynapse, 1996
- Phorbol esters alter functions of the expressed dopamine transporterEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- A Molecular Glimpse of Vesicular Monoamine TransportersJournal of Neurochemistry, 1994
- Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neuronsAnnals of Neurology, 1994
- A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPsFEBS Letters, 1993
- Cloning and functional characterization of a cocaine‐sensitive dopamine transporterFEBS Letters, 1991
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Preservation of hypothalamic dopaminergic neurons in Parkinson's diseaseAnnals of Neurology, 1985